A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-12
DOI
10.3389/fimmu.2020.573526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV
- (2020) Jia Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
- (2020) Adarsh Bhimraj et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
- (2020) Pingzheng Mo et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Antibody Detection and Dynamic Characteristics in Patients with COVID-19
- (2020) Fei Xiang et al. CLINICAL INFECTIOUS DISEASES
- Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
- (2020) Ranawaka APM Perera et al. Eurosurveillance
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples
- (2020) Alessandro Manenti et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
- (2020) Alexandra L Phelan LANCET
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- SARS-CoV-2 (COVID-19) by the numbers
- (2020) Yinon M Bar-On et al. eLife
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
- (2020) Antonio E. Muruato et al. Nature Communications
- No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
- (2020) Julia Schwaiger et al. JOURNAL OF INFECTIOUS DISEASES
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- Structures and distributions of SARS-CoV-2 spike proteins on intact virions
- (2020) Zunlong Ke et al. NATURE
- Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue
- (2018) Melissa C. Whiteman et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Highly individual patterns of virus-immune IgG effector responses in humans
- (2016) Eugenia Corrales-Aguilar et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Exploitation of Herpesviral Transactivation Allows Quantitative Reporter Gene-Based Assessment of Virus Entry and Neutralization
- (2011) Henrike Reinhard et al. PLoS One
- Gamma Interferon-Induced Interferon Regulatory Factor 1-Dependent Antiviral Response Inhibits Vaccinia Virus Replication in Mouse but Not Human Fibroblasts
- (2009) M. Trilling et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now